Retrieved on:
Wednesday, November 8, 2023
SCRS,
FDA,
DCT,
Biomedical Advanced Research and Development Authority,
Office of the National Coordinator for Health Information Technology,
National Institutes of Health,
Face,
European Medicines Agency,
Organization,
BARDA,
Entrepreneurship,
Research,
Development,
DTRA,
DCTS,
Clinical trial,
Decentralized Trials & Research Alliance,
EMA,
Annual general meeting,
NIH,
Government agency,
ONC,
Chairperson,
Map,
Government,
SAN,
Pharmaceutical industry,
Medical device SAN DIEGO, Nov. 08, 2023 (GLOBE NEWSWIRE) -- The Decentralized Trials & Research Alliance (DTRA), a global alliance focused on the adoption of decentralized trials, today concluded its 2023 Annual Meeting, including members from biopharmaceutical companies, government agencies, research sites, healthcare organizations, patient groups, and service and technology companies.
Key Points:
- SAN DIEGO, Nov. 08, 2023 (GLOBE NEWSWIRE) -- The Decentralized Trials & Research Alliance (DTRA), a global alliance focused on the adoption of decentralized trials, today concluded its 2023 Annual Meeting, including members from biopharmaceutical companies, government agencies, research sites, healthcare organizations, patient groups, and service and technology companies.
- The DTRA community learned of their strategic intentions regarding decentralized clinical trial (DCT) adoption, drivers to achieve scale with these methods, and the importance of DCT to our research ecosystem.
- DTRA has harnessed this industry-leading expertise into creating new resources, sharing key learnings, and establishing best practices for research teams to use in implementing DCTs.
- “Each of our Initiative outputs is available at www.dtra.org and the resources are available to all.”
Customer success,
Clinical trial,
Decentralized Trials & Research Alliance,
Research,
DCTS,
DTRA,
Patient engagement in Canada,
Thought,
Medidata Solutions,
Patient,
SAN,
Vaccine,
Team,
Pharmaceutical industry,
Nursing,
Medical imaging SAN DIEGO, April 25, 2023 (GLOBE NEWSWIRE) -- The Decentralized Trials & Research Alliance (DTRA) today has announced the release of Patient Journey Maps to help researchers understand participation considerations and burden and to maximize patient inclusion, diversity, and participation in research.
Key Points:
- SAN DIEGO, April 25, 2023 (GLOBE NEWSWIRE) -- The Decentralized Trials & Research Alliance (DTRA) today has announced the release of Patient Journey Maps to help researchers understand participation considerations and burden and to maximize patient inclusion, diversity, and participation in research.
- “The patient journey maps can be used as guidelines for others in the industry to find ways to truly embrace the patient perspective when it comes to decentralized clinical trials,” said Alicia Staley, Vice President of Patient Engagement at Medidata and Co-Lead of the DTRA Patient Journey Map initiative.
- Our team delivered a unique set of patient journey maps across three different therapeutic areas, which will enhance access and engagement in clinical trials.”
By visualizing the decision points that patients face in their treatment and clinical research experience, study teams can fully appreciate and anticipate the patient journey.
- “We have successfully identified the patient journey for incorporating Decentralized Clinical Trials (DCTs) in clinical trials.
Retrieved on:
Friday, February 24, 2023
Clinical trial,
Ecosystem,
Regulation,
Drug development,
Decentralized Trials & Research Alliance,
Patient,
DCT,
SAN,
DTRA,
Operational definition,
Patient experience,
Pharmaceutical industry,
Risk management,
Success,
Rubric SAN DIEGO, Feb. 24, 2023 (GLOBE NEWSWIRE) -- The Decentralized Trials & Research Alliance (DTRA), today announced the release of the Best Practices Rubric to aid stakeholders in evaluating decentralized clinical trial (DCT) best practices across the span of the trial lifecycle, from program planning to trial close and analysis.
Key Points:
- SAN DIEGO, Feb. 24, 2023 (GLOBE NEWSWIRE) -- The Decentralized Trials & Research Alliance (DTRA), today announced the release of the Best Practices Rubric to aid stakeholders in evaluating decentralized clinical trial (DCT) best practices across the span of the trial lifecycle, from program planning to trial close and analysis.
- This Rubric solves the problem: How would you assess whether a process is a DCT best practice?
- The Rubric provides a consistent framework by which DCT practices may be evaluated.
- Mike DeMarco shared “The DTRA Best Practices Rubric provides a consistent framework by which DCT practices may be evaluated.
Retrieved on:
Wednesday, September 29, 2021
Adoption,
News,
Therapy,
Clinical trial,
Decentralized Trials & Research Alliance,
Efficiency,
Brown University,
DCTS,
Boston Medical Center,
Health,
Culture,
Multimedia,
DCT,
MD,
DTRA,
CEO,
Leadership,
Technology,
View,
Research,
Machine learning,
Cloud computing,
Industry,
Education,
Travel,
Pharmaceutical industry BOSTON, Sept. 29, 2021 /PRNewswire/ -- Curavit Clinical Research , a virtual contract research organization (VCRO) that designs and executes decentralized clinical trials (DCTs), announced today that it has joined the Decentralized Trials & Research Alliance (DTRA) to further the advancement and adoption of decentralized clinicals.
Key Points:
- BOSTON, Sept. 29, 2021 /PRNewswire/ -- Curavit Clinical Research , a virtual contract research organization (VCRO) that designs and executes decentralized clinical trials (DCTs), announced today that it has joined the Decentralized Trials & Research Alliance (DTRA) to further the advancement and adoption of decentralized clinicals.
- Established in 2020, the DTRA enables collaboration of stakeholders to accelerate the adoption of patient-focused, decentralized clinical trials and research within life sciences and healthcare through education and research.
- It works to make research participation accessible to everyone, enabled by the consistent, widespread adoption of appropriate decentralized research methods.
- Curavit Clinical Research is a virtual contract research organization (VCRO) that designs and executes Decentralized Clinical Trials (DCTs).
KING OF PRUSSIA, Pa., June 2, 2021 /PRNewswire/ -- Greenphire , the global leader in financial lifecycle management for clinical trials, has announced today that it has joined the Decentralized Trials & Research Alliance (DTRA), a burgeoning alliance of 100 life science and healthcare organizations that seek to accelerate the adoption of patient-focused, decentralized clinical trials and research.
Key Points:
- KING OF PRUSSIA, Pa., June 2, 2021 /PRNewswire/ -- Greenphire , the global leader in financial lifecycle management for clinical trials, has announced today that it has joined the Decentralized Trials & Research Alliance (DTRA), a burgeoning alliance of 100 life science and healthcare organizations that seek to accelerate the adoption of patient-focused, decentralized clinical trials and research.
- "We are extremely gratified to welcome Greenphire to the Decentralized Trials & Research Alliance," said Amir Kalali, MD, founder of several collaborative life science communities, and co-convenor of DTRA.
- The Decentralized Trials & Research Alliance ( DTRA ) was convened to enable collaboration of stakeholders to accelerate the adoption of patient-focused, decentralized clinical trials and research within life sciences and healthcare through education and research.
- It works to make research participation accessible to everyone, enabled by the consistent, widespread adoption of appropriate decentralized research methods.
